Latest Market Growth News

Page 1 of 20
Revvity has set out a long-range growth strategy built around AI-enabled scientific discovery, recurring software revenue and specialised diagnostics. The plan includes double-digit adjusted EPS growth, margin expansion and about US$5 billion of capital capacity through 2031, but formal 2027 guidance is still pending.
Ada Torres
Ada Torres
14 Nov 2026
CDW delivered a sharp third-quarter sales increase and lifted its quarterly dividend by about 8%, helped by demand for servers, storage, mobile devices and software. The stronger earnings picture came with lower gross margins, higher debt and weaker operating cash flow than a year earlier.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.
Victor Sage
Victor Sage
26 Oct 2026
MA Financial delivered strong third-quarter growth across lending, asset management and advisory, while warning that residential property credit conditions have forced a temporary redemption suspension. The group still expects underlying FY26 EPS to be materially higher than FY25.
Claire Turing
Claire Turing
21 Oct 2026
PointsBet expects first-half FY27 revenue of approximately $113 million, down 16% from the prior corresponding period, with normalised EBITDA falling to a loss of $6 million to $8 million. The company attributed the setback to stricter Australian compliance measures and adverse betting results, particularly in AFL.
Victor Sage
Victor Sage
13 Oct 2026
Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.
Ada Torres
Ada Torres
31 Aug 2026
Vmoto Limited posted its strongest half-year sales ever with $35.7 million revenue and a 140% surge in unit sales, underpinned by new global partnerships and international market growth.
Victor Sage
Victor Sage
31 Aug 2026
Singular Health Group lifted revenues over fivefold to $1.43 million in FY26, driven by US commercial rollouts of its 3DICOM platform, but posted a $6.34 million loss. The company strengthened its US foothold with FDA clearance and a controlling stake in an associate.
Victor Sage
Victor Sage
31 Aug 2026
Me Today Limited delivered a 36% revenue surge to $7.96 million in FY26, cutting its EBITDA loss by 43% and locking in $1.59 million of new capital from major shareholders ahead of October warrant exercises.
Victor Sage
Victor Sage
27 Aug 2026
Pengana Capital Group reported a statutory loss of $5.6 million for FY26 despite a 14% rise in funds under management, driven by upfront costs linked to new product launches and expanding private credit platforms.
Claire Turing
Claire Turing
26 Aug 2026
Nine Entertainment Co. Holdings Limited posted a $511 million statutory net profit for FY26, driven by significant portfolio restructuring and growth in digital and outdoor advertising, while advancing AI licensing partnerships.
Victor Sage
Victor Sage
26 Aug 2026
Big River Industries (ASX:BRI) reversed a $14.8 million loss in FY25 to a $4.9 million profit in FY26, driven by margin expansion and the acquisition of Johns Building Supplies. The group targets double-digit EBITDA growth in FY27 amid mixed market conditions.
Victor Sage
Victor Sage
25 Aug 2026

Browse the archive

Full archive